Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer

Fumihiko Ando(Nippon Medical School), Yoshiko Iwai(Nippon Medical School)

Frontiers in Pharmacology

May 7, 2024

10.3389/fphar.2024.1384731

Cited by 6

Related Papers

Clinical significance of PD-1-binding soluble PD-L1 and MMPs in the microenvironment of gastric cancer and non-small cell lung cancer treated with PD-1/PD-L1 blockade

|medRxiv|2024|0